One thing I don't get with BP is that they know the stock quite well and how it moves yet they have such a conservative price target on it at the same time that they say........"Once the FDA process begins US instos tend to have a good look at these type of companies, as do the big pharmaceutical companies, so the could be something ( a lot actually) coming from that front(the US) in 2021."..... yet have a $3.17 price target on it from BP? Not sure how they think that will be possible without a substantial rise in the SP - we just don't have that sort of liquidity. If US Insto's took an interest and decided to build even a starting share holding it will be double this SP to get there. imo of course
One thing I don't get with BP is that they know the stock quite...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 26.5¢ | 25.5¢ | $61.58K | 238.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 62473 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.0¢ |
Change
-0.005 ( 1.07 %) |
||||
| Open | High | Low | Volume | ||
| 26.5¢ | 26.5¢ | 25.5¢ | 105880 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| PAR (ASX) Chart |